Brief: Polyphor Receives Approval To Start First-In-Human Clinical Trial Of Inhaled Antibiotic Murepavadin

Spexis AG

22/12/2020 06:31

Dec 22 (Reuters) - POLYPHOR AG  POLN.S :
    * RECEIVES APPROVAL TO START FIRST-IN-HUMAN CLINICAL TRIAL
OF
INHALED ANTIBIOTIC MUREPAVADIN
    * PHASE IB/IIA TRIAL IN ADULTS WITH CF, ASSESSING SAFETY AND
TOLERABILITY OF ASCENDING DOSES OF INHALED MUREPAVADIN, IS
PLANNED TO BE INITIATED FOLLOWING COMPLETION OF PHASE I STUDY IN
2021

Source text for Eikon:  ID:nEQbqZ8HMa 
Further company coverage:  POLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))